Public dataset
Recorded source agreement and disagreement
Show whether sources print one normalized reading, have incompatible units, lack structured comparison context, or contain a context-matched numeric difference.
- Public rows
- 1,681
- Generated
- Schema version
- source-consensus/2
Coverage
What this run contains
- Compared medicine fields
- 1,681
- Agree
- 1,282
- Differ
- 0
- Not comparable
- 12
- Insufficient context
- 387
- Fields represented
- 5
- bioavailability, halfLife, proteinBinding, tMax, volumeOfDistribution
Method
How the rows were made
- Deterministic rules normalize recorded pharmacokinetic readings and compare only like-for-like values.
- One normalized printed reading may be agree even when clinical context was not extracted; this reports printed-reading agreement only.
- Distinct readings may differ only when their units and denominators are comparable and one matching, non-placeholder population/formulation context was structurally extracted. Otherwise they are insufficient_context.
- not_comparable preserves incompatible units or denominators instead of guessing. insufficient_context preserves missing or non-matching structured context instead of manufacturing agreement or disagreement.
- The agreement rate describes the distribution of recorded source readings; it is not a probability that a value is true.
- Every distinct printed reading retains its unit, population context, source count, and complete source records. The API paginates field rows, never child readings or sources.
- documentsExamined is every matching single-substance archive document inspected for that medicine. The generator has no document, reading, or source ceiling, so there is no hidden available-versus-retained remainder.
Limits
Read these before using a row
- Current label parsing does not structurally extract population or formulation context. Distinct otherwise-comparable readings are therefore insufficient_context, never differ; agree may mean printed-reading agreement only. Source records are complete but are not independent-experiment counts.
- The current deterministic parser does not structurally extract population or formulation context from these sentences. It records that context as unknown and cannot publish distinct same-unit readings as differ.
- Neither reading is marked wrong. Population, formulation, route, and other unextracted context may explain the printed difference.
- Only the recorded fields and source documents in this snapshot are compared.
- A source count is the number of retained source records in the row, not a count of independent experiments.
Provenance
Source examples
abacavir · bioavailability · agree
15 documents examined; 83% (Unknown: population and formulation context were not structurally extracted from this source sentence.)
FDA_LABEL:5676d391-f9a4-44be-9604-954b3d8d0e2b (opens source in a new tab)The geometric mean absolute bioavailability of the tablet was 83%.
alemtuzumab · volumeOfDistribution · not_comparable
2 documents examined; 0.18 L/kg (Unknown: population and formulation context were not structurally extracted from this source sentence.); 14.1 L (Unknown: population and formulation context were not structurally extracted from this source sentence.)
FDA_LABEL:4f5f7255-7abc-4328-bd1a-ceaf139ef3e0 (opens source in a new tab)Distribution After the last 30 mg dose, the mean volume of distribution at steady-state was 0.18 L/kg (range 0.1 to 0.4 L/kg).
abiraterone · halfLife · insufficient_context
31 documents examined; 12 ± 5 hours (Unknown: population and formulation context were not structurally extracted from this source sentence.); 18 hours (Unknown: population and formulation context were not structurally extracted from this source sentence.)
FDA_LABEL:c9eb9b46-f847-40a8-802c-a51b40406d5a (opens source in a new tab)Elimination In patients with metastatic CRPC, the mean terminal half-life of abiraterone in plasma (mean ± SD) is 12 ± 5 hours.
Artifact used for this view: data/source-consensus.ndjson. The reader resolves the current run first and uses the checked-in compatibility run only when a current artifact is absent.
Schema
Fields in the public projection
| Field | Type | Meaning |
|---|---|---|
| medicineSlug | string | Stable RNAWiki medicine route key. |
| field | string | Recorded pharmacokinetic field being compared. |
| comparisonState | string | agree (printed-reading agreement), differ (context-matched comparable disjoint values), not_comparable (unit/denominator mismatch), or insufficient_context. Every state remains declared even when its current count is zero. |
| comparisonReasons | string[] | Deterministic codes explaining the state. |
| documentsExamined | number | Recorded source documents considered for the field. |
| sourceCount | number | Recorded source readings represented. |
| agreementRate | number | Share represented by the leading normalized printed-reading group; not a confidence score or clinical agreement probability. |
| readings | consensus-reading[] | Complete, untruncated reading groups. Each keeps the printed display, numeric value when parsed, unit, population context, source count, and every source identity, version/effective date or explicit absence, retrieval date, locator, safe link, and excerpt. |
Reader
Search and filter the rows
Showing 1,281–1,290 of 1,681 matching rows. Filters and search terms remain attached when you move between pages or open the API view.
Projected row 1281
- Medicine slug
- quetiapine
- Compared field
- tMax
- Comparison state
- agree
- Reason codes
- COMPATIBLE_VALUES_OVERLAP
- Documents examined
- 148
- Source count
- 26
- Agreement rate
- 1
- Recorded readings
6 hours
- Numeric value
- 6
- Unit
- hours
- Source records
- 26
Population and context: Unknown: population and formulation context were not structurally extracted from this source sentence.
Show all 26 source records
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:c6e25a58-96b4-47b7-a5f3-33e5ffce1d1e (opens source in a new tab)
Quetiapine label
Version not recorded · Effective date not recorded
Absorption Quetiapine reaches peak plasma concentrations approximately 6 hours following administration.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:3ffe0294-3959-2755-e054-00144ff8d46c (opens source in a new tab)
Quetiapine label
Version not recorded · Effective date not recorded
Absorption Quetiapine fumarate reaches peak plasma concentrations approximately 6 hours following administration.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:67872105-4ec6-4d46-b3b4-c672c93576d2 (opens source in a new tab)
Quetiapine label
Version not recorded · Effective date not recorded
Absorption Quetiapine reaches peak plasma concentrations approximately 6 hours following administration.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:d699b8c7-8a1c-44ed-85d8-c821a9c8c848 (opens source in a new tab)
Quetiapine label
Version not recorded · Effective date not recorded
Absorption Quetiapine reaches peak plasma concentrations approximately 6 hours following administration.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:a373a57d-1dee-4bd1-b71b-494e1662f558 (opens source in a new tab)
Quetiapine label
Version not recorded · Effective date not recorded
Absorption Quetiapine reaches peak plasma concentrations approximately 6 hours following administration.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:e3c2740c-a77a-428d-a99b-f78d8e530acd (opens source in a new tab)
Quetiapine label
Version not recorded · Effective date not recorded
Absorption Quetiapine reaches peak plasma concentrations approximately 6 hours following administration.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:db3ba268-21a2-4988-b5c1-353741bcaee5 (opens source in a new tab)
Quetiapine label
Version not recorded · Effective date not recorded
Absorption Quetiapine reaches peak plasma concentrations approximately 6 hours following administration.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:7803a290-91c0-4e7f-90b5-d2ff33a46cee (opens source in a new tab)
Quetiapine label
Version not recorded · Effective date not recorded
Absorption Quetiapine reaches peak plasma concentrations approximately 6 hours following administration. quetiapine extended-release tablet dosed once daily at steady state has comparable bioavailability to an equivalent total daily dose of SEROQUEL administered in divided doses, twice daily.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:473a3ac4-67f4-4782-baa9-7f9bdd8761f4 (opens source in a new tab)
Quetiapine label
Version not recorded · Effective date not recorded
Absorption Quetiapine reaches peak plasma concentrations approximately 6 hours following administration.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:3622cbd4-d7cb-57d4-e063-6294a90a5f24 (opens source in a new tab)
Quetiapine label
Version not recorded · Effective date not recorded
Absorption Quetiapine reaches peak plasma concentrations approximately 6 hours following administration.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:44e9b338-b163-bee7-e063-6394a90a1338 (opens source in a new tab)
Quetiapine label
Version not recorded · Effective date not recorded
Absorption Quetiapine reaches peak plasma concentrations approximately 6 hours following administration.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:8923c441-c9aa-4b30-89d7-dbaaa7f66656 (opens source in a new tab)
Quetiapine label
Version not recorded · Effective date not recorded
Absorption Quetiapine reaches peak plasma concentrations approximately 6 hours following administration.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:b0cce89c-0e84-4f60-8e50-0e26c41c2613 (opens source in a new tab)
Quetiapine label
Version not recorded · Effective date not recorded
Absorption Quetiapine reaches peak plasma concentrations approximately 6 hours following administration.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:61695b42-cf71-43e3-8b5d-788fd439489f (opens source in a new tab)
Quetiapine label
Version not recorded · Effective date not recorded
Absorption Quetiapine reaches peak plasma concentrations approximately 6 hours following administration.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:6562eb60-0d70-4909-bd07-88d5c9241516 (opens source in a new tab)
Quetiapine label
Version not recorded · Effective date not recorded
Absorption Quetiapine reaches peak plasma concentrations approximately 6 hours following administration.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:72111c36-c625-434f-9f16-7f25e0ff75f3 (opens source in a new tab)
Quetiapine label
Version not recorded · Effective date not recorded
Absorption Quetiapine fumarate reaches peak plasma concentrations approximately 6 hours following administration.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:b78b4e12-8ec4-470d-9bb5-665b5af328f5 (opens source in a new tab)
Quetiapine label
Version not recorded · Effective date not recorded
Absorption Quetiapine reaches peak plasma concentrations approximately 6 hours following administration.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:995731f7-aace-4140-b699-d6e8975c7c83 (opens source in a new tab)
Quetiapine label
Version not recorded · Effective date not recorded
Absorption Quetiapine reaches peak plasma concentrations approximately 6 hours following administration.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:b02324b1-e7f0-4cbc-8778-5f7c4a5d194a (opens source in a new tab)
Quetiapine label
Version not recorded · Effective date not recorded
Absorption Quetiapine reaches peak plasma concentrations approximately 6 hours following administration. quetiapine extended-release tablet dosed once daily at steady state has comparable bioavailability to an equivalent total daily dose of SEROQUEL administered in divided doses, twice daily.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:04cd529c-198b-5b85-e063-6294a90a4684 (opens source in a new tab)
Quetiapine label
Version not recorded · Effective date not recorded
Absorption Quetiapine reaches peak plasma concentrations approximately 6 hours following administration.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:ab959a35-d0ba-4f18-8f2e-6619d88b16e3 (opens source in a new tab)
Quetiapine label
Version not recorded · Effective date not recorded
Absorption Quetiapine reaches peak plasma concentrations approximately 6 hours following administration.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:90da6c48-3282-41dc-b4fa-75d33efa9fee (opens source in a new tab)
Quetiapine label
Version not recorded · Effective date not recorded
Absorption Quetiapine reaches peak plasma concentrations approximately 6 hours following administration.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:5e4a84b1-fb8c-44d0-8213-51e43d71db69 (opens source in a new tab)
Quetiapine label
Version not recorded · Effective date not recorded
Absorption Quetiapine reaches peak plasma concentrations approximately 6 hours following administration.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:07e4f3f4-42cb-4b22-bf8d-8c3279d26e97 (opens source in a new tab)
Quetiapine label
Version not recorded · Effective date not recorded
Absorption Quetiapine fumarate reaches peak plasma concentrations approximately 6 hours following administration.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:461523b5-8d12-9d96-e063-6394a90ad4c2 (opens source in a new tab)
Quetiapine label
Version not recorded · Effective date not recorded
Absorption Quetiapine reaches peak plasma concentrations approximately 6 hours following administration.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:186c5cde-5066-4436-99ef-28049c12826b (opens source in a new tab)
Quetiapine label
Version not recorded · Effective date not recorded
Absorption Quetiapine reaches peak plasma concentrations approximately 6 hours following administration.
Projected row 1282
- Medicine slug
- quetiapine
- Compared field
- volumeOfDistribution
- Comparison state
- agree
- Reason codes
- COMPATIBLE_VALUES_OVERLAP
- Documents examined
- 148
- Source count
- 148
- Agreement rate
- 1
- Recorded readings
10±4 L/kg
- Numeric value
- 10
- Unit
- L/kg
- Source records
- 148
Population and context: Unknown: population and formulation context were not structurally extracted from this source sentence.
Show all 148 source records
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:e6e25ef9-2671-489e-8eca-58bedb4f59ab (opens source in a new tab)
Quetiapine label
Version not recorded · Effective date not recorded
Distribution Quetiapine is widely distributed throughout the body with an apparent volume of distribution of 10±4 L/kg.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:32bc1ecb-7285-4013-b266-ca783a62d617 (opens source in a new tab)
Quetiapine label
Version not recorded · Effective date not recorded
Distribution Quetiapine is widely distributed throughout the body with an apparent volume of distribution of 10±4 L/kg.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:aeff3ab1-24ff-417a-8bbc-2ffa413dcb87 (opens source in a new tab)
Quetiapine label
Version not recorded · Effective date not recorded
Distribution Quetiapine is widely distributed throughout the body with an apparent volume of distribution of 10±4 L/kg.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:c6e25a58-96b4-47b7-a5f3-33e5ffce1d1e (opens source in a new tab)
Quetiapine label
Version not recorded · Effective date not recorded
Distribution Quetiapine is widely distributed throughout the body with an apparent volume of distribution of 10±4 L/kg.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:da3c9642-9f8d-422b-8e12-2036d68f78ca (opens source in a new tab)
Quetiapine label
Version not recorded · Effective date not recorded
Distribution Quetiapine is widely distributed throughout the body with an apparent volume of distribution of 10±4 L/kg.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:6258bbaf-4ac0-4621-b95e-e6b032aa0518 (opens source in a new tab)
Quetiapine label
Version not recorded · Effective date not recorded
Distribution Quetiapine is widely distributed throughout the body with an apparent volume of distribution of 10±4 L/kg.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:60316ccd-c042-4ea0-9d05-3caf7cc2cab1 (opens source in a new tab)
Quetiapine label
Version not recorded · Effective date not recorded
Distribution: Quetiapine is widely distributed throughout the body with an apparent volume of distribution of 10±4 L/kg.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:3ffe0294-3959-2755-e054-00144ff8d46c (opens source in a new tab)
Quetiapine label
Version not recorded · Effective date not recorded
Distribution Quetiapine is widely distributed throughout the body with an apparent volume of distribution of 10±4 L/kg.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:532c8ace-4cf5-4a08-bae7-2af8c41ffa3d (opens source in a new tab)
Quetiapine label
Version not recorded · Effective date not recorded
Distribution Quetiapine is widely distributed throughout the body with an apparent volume of distribution of 10±4 L/kg.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:6b7d7d2f-a50b-8e21-2de4-ccc102016384 (opens source in a new tab)
Quetiapine label
Version not recorded · Effective date not recorded
Distribution Quetiapine is widely distributed throughout the body with an apparent volume of distribution of 10±4 L/kg.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:bdc9354b-172e-4bb3-895a-6c7cfef0ef14 (opens source in a new tab)
Quetiapine label
Version not recorded · Effective date not recorded
Distribution Quetiapine is widely distributed throughout the body with an apparent volume of distribution of 10±4 L/kg.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:1fe839fa-c566-4374-997f-f5b9d97b5fb8 (opens source in a new tab)
Quetiapine label
Version not recorded · Effective date not recorded
Distribution Quetiapine is widely distributed throughout the body with an apparent volume of distribution of 10±4 L/kg.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:45c4c3a4-3acc-413e-9746-4816d513fac6 (opens source in a new tab)
Quetiapine label
Version not recorded · Effective date not recorded
Distribution Quetiapine is widely distributed throughout the body with an apparent volume of distribution of 10±4 L/kg.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:8df82f5a-aa0e-4f8c-bae1-2f32ede3d7b6 (opens source in a new tab)
Quetiapine label
Version not recorded · Effective date not recorded
Distribution Quetiapine is widely distributed throughout the body with an apparent volume of distribution of 10±4 L/kg.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:fd9cce28-0052-4b0b-8a66-a1615e082d95 (opens source in a new tab)
Quetiapine label
Version not recorded · Effective date not recorded
Distribution Quetiapine is widely distributed throughout the body with an apparent volume of distribution of 10±4 L/kg.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:d38f0f4e-dc0f-4c92-a212-c4da3db74801 (opens source in a new tab)
Quetiapine label
Version not recorded · Effective date not recorded
Distribution Quetiapine is widely distributed throughout the body with an apparent volume of distribution of 10±4 L/kg.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:67872105-4ec6-4d46-b3b4-c672c93576d2 (opens source in a new tab)
Quetiapine label
Version not recorded · Effective date not recorded
Distribution Quetiapine is widely distributed throughout the body with an apparent volume of distribution of 10±4 L/kg.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:02b19885-2987-4c46-8d2a-5e59656f72e8 (opens source in a new tab)
Quetiapine label
Version not recorded · Effective date not recorded
Distribution Quetiapine is widely distributed throughout the body with an apparent volume of distribution of 10±4 L/kg.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:d699b8c7-8a1c-44ed-85d8-c821a9c8c848 (opens source in a new tab)
Quetiapine label
Version not recorded · Effective date not recorded
Distribution Quetiapine is widely distributed throughout the body with an apparent volume of distribution of 10±4 L/kg.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:d779f317-683b-4ec6-a309-1dd54332563f (opens source in a new tab)
Quetiapine label
Version not recorded · Effective date not recorded
Distribution Quetiapine is widely distributed throughout the body with an apparent volume of distribution of 10±4 L/kg.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:85f973e0-93e6-4856-9266-62136acb2532 (opens source in a new tab)
Quetiapine label
Version not recorded · Effective date not recorded
Distribution Quetiapine is widely distributed throughout the body with an apparent volume of distribution of 10±4 L/kg.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:227b8b2b-a238-efb4-e063-6394a90acc7e (opens source in a new tab)
Quetiapine label
Version not recorded · Effective date not recorded
Distribution Quetiapine is widely distributed throughout the body with an apparent volume of distribution of 10±4 L/kg.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:fceb9f47-8da7-7138-e053-6294a90a5558 (opens source in a new tab)
Quetiapine label
Version not recorded · Effective date not recorded
Distribution Quetiapine is widely distributed throughout the body with an apparent volume of distribution of 10±4 L/kg.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:d73655d3-4b3f-40b4-92cb-053ad4f21a92 (opens source in a new tab)
Quetiapine label
Version not recorded · Effective date not recorded
Distribution Quetiapine is widely distributed throughout the body with an apparent volume of distribution of 10±4 L/kg.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:a373a57d-1dee-4bd1-b71b-494e1662f558 (opens source in a new tab)
Quetiapine label
Version not recorded · Effective date not recorded
Distribution Quetiapine is widely distributed throughout the body with an apparent volume of distribution of 10±4 L/kg.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:49ebd00b-e0a2-45c3-9cff-4b94d1a6b5ad (opens source in a new tab)
Quetiapine label
Version not recorded · Effective date not recorded
Distribution Quetiapine is widely distributed throughout the body with an apparent volume of distribution of 10±4 L/kg.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:479c9555-5d1e-4e5c-bfde-f3812829edd8 (opens source in a new tab)
Quetiapine label
Version not recorded · Effective date not recorded
Distribution Quetiapine is widely distributed throughout the body with an apparent volume of distribution of 10±4 L/kg.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:5c6aeb85-3ac2-4448-b544-9a4c5f562ed3 (opens source in a new tab)
Quetiapine label
Version not recorded · Effective date not recorded
Distribution Quetiapine is widely distributed throughout the body with an apparent volume of distribution of 10±4 L/kg.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:10288afa-c4dc-4897-9ec8-f4573d850779 (opens source in a new tab)
Quetiapine label
Version not recorded · Effective date not recorded
Distribution Quetiapine is widely distributed throughout the body with an apparent volume of distribution of 10±4 L/kg.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:2d77412a-e084-4406-ac33-d882aece9354 (opens source in a new tab)
Quetiapine label
Version not recorded · Effective date not recorded
Distribution Quetiapine is widely distributed throughout the body with an apparent volume of distribution of 10±4 L/kg.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:5643d339-50ea-405d-e063-6394a90a3b70 (opens source in a new tab)
Quetiapine label
Version not recorded · Effective date not recorded
Distribution Quetiapine is widely distributed throughout the body with an apparent volume of distribution of 10±4 L/kg.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:711f42c5-0719-46de-81fb-3d03801b9ed9 (opens source in a new tab)
Quetiapine label
Version not recorded · Effective date not recorded
Distribution Quetiapine is widely distributed throughout the body with an apparent volume of distribution of 10±4 L/kg.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:458cae68-c11d-e760-e063-6394a90ac04e (opens source in a new tab)
Quetiapine label
Version not recorded · Effective date not recorded
Distribution Quetiapine is widely distributed throughout the body with an apparent volume of distribution of 10±4 L/kg.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:face6c19-3dd9-b188-e053-6294a90a62d0 (opens source in a new tab)
Quetiapine label
Version not recorded · Effective date not recorded
Distribution Quetiapine is widely distributed throughout the body with an apparent volume of distribution of 10±4 L/kg.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:c1f2ccba-62f3-44e7-b06f-dea61eac9e93 (opens source in a new tab)
Quetiapine label
Version not recorded · Effective date not recorded
Distribution Quetiapine is widely distributed throughout the body with an apparent volume of distribution of 10±4 L/kg.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:1a147d6c-8af8-4379-8a13-1864a9a79b84 (opens source in a new tab)
Quetiapine label
Version not recorded · Effective date not recorded
Distribution Quetiapine is widely distributed throughout the body with an apparent volume of distribution of 10±4 L/kg.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:ccacb909-8ee5-4223-bfee-9cfeae470ecf (opens source in a new tab)
Quetiapine label
Version not recorded · Effective date not recorded
Distribution Quetiapine is widely distributed throughout the body with an apparent volume of distribution of 10±4 L/kg.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:93ab6237-321e-4a2c-b0ca-3fc9acb31f9a (opens source in a new tab)
Quetiapine label
Version not recorded · Effective date not recorded
Distribution Quetiapine is widely distributed throughout the body with an apparent volume of distribution of 10 ± 4 L/kg.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:385f7c3d-3299-4b04-947e-de2ee78c8241 (opens source in a new tab)
Quetiapine label
Version not recorded · Effective date not recorded
Distribution Quetiapine is widely distributed throughout the body with an apparent volume of distribution of 10±4 L/kg.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:e3c2740c-a77a-428d-a99b-f78d8e530acd (opens source in a new tab)
Quetiapine label
Version not recorded · Effective date not recorded
Distribution Quetiapine is widely distributed throughout the body with an apparent volume of distribution of 10±4 L/kg.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:f9447739-9e21-4232-950f-174c0496ab66 (opens source in a new tab)
Quetiapine label
Version not recorded · Effective date not recorded
Distribution Quetiapine is widely distributed throughout the body with an apparent volume of distribution of 10±4 L/kg.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:db3ba268-21a2-4988-b5c1-353741bcaee5 (opens source in a new tab)
Quetiapine label
Version not recorded · Effective date not recorded
Distribution Quetiapine is widely distributed throughout the body with an apparent volume of distribution of 10±4 L/kg.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:c1d4ef59-bf58-44fe-9b46-1af42e2f7f8b (opens source in a new tab)
Quetiapine label
Version not recorded · Effective date not recorded
Distribution Quetiapine is widely distributed throughout the body with an apparent volume of distribution of 10±4 L/kg.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:f6de1d2b-b10e-2e9a-e053-6394a90a735d (opens source in a new tab)
Quetiapine label
Version not recorded · Effective date not recorded
Distribution Quetiapine is widely distributed throughout the body with an apparent volume of distribution of 10±4 L/kg.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:874e50ad-5da0-4ac3-9290-79442c91399e (opens source in a new tab)
Quetiapine label
Version not recorded · Effective date not recorded
Distribution Quetiapine is widely distributed throughout the body with an apparent volume of distribution of 10±4 L/kg.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:7803a290-91c0-4e7f-90b5-d2ff33a46cee (opens source in a new tab)
Quetiapine label
Version not recorded · Effective date not recorded
Distribution Quetiapine is widely distributed throughout the body with an apparent volume of distribution of 10±4 L/kg.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:473a3ac4-67f4-4782-baa9-7f9bdd8761f4 (opens source in a new tab)
Quetiapine label
Version not recorded · Effective date not recorded
Distribution Quetiapine is widely distributed throughout the body with an apparent volume of distribution of 10±4 L/kg.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:52ba669d-c846-03c2-e063-6394a90ac0f0 (opens source in a new tab)
Quetiapine label
Version not recorded · Effective date not recorded
Distribution Quetiapine is widely distributed throughout the body with an apparent volume of distribution of 10±4 L/kg.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:544f6e91-e61f-c57a-e063-6294a90af9d1 (opens source in a new tab)
Quetiapine label
Version not recorded · Effective date not recorded
Distribution Quetiapine is widely distributed throughout the body with an apparent volume of distribution of 10±4 L/kg.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:36248b77-277c-7d66-e063-6394a90ae1e8 (opens source in a new tab)
Quetiapine label
Version not recorded · Effective date not recorded
Distribution Quetiapine is widely distributed throughout the body with an apparent volume of distribution of 10±4 L/kg.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:559fdce5-ab3e-0d02-e063-6394a90a7fbd (opens source in a new tab)
Quetiapine label
Version not recorded · Effective date not recorded
Distribution Quetiapine is widely distributed throughout the body with an apparent volume of distribution of 10±4 L/kg.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:132a2483-7e49-4b0c-9db4-e6e578697fd9 (opens source in a new tab)
Quetiapine label
Version not recorded · Effective date not recorded
Distribution Quetiapine is widely distributed throughout the body with an apparent volume of distribution of 10±4 L/kg.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:8048ac0a-5d4d-4d00-ab9c-7fcac27f0a60 (opens source in a new tab)
Quetiapine label
Version not recorded · Effective date not recorded
Distribution Quetiapine is widely distributed throughout the body with an apparent volume of distribution of 10±4 L/kg.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:d323b6c0-55fa-6caa-e053-2a95a90a3cff (opens source in a new tab)
Quetiapine label
Version not recorded · Effective date not recorded
Distribution Quetiapine is widely distributed throughout the body with an apparent volume of distribution of 10±4 L/kg.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:8acc0ed3-6e4f-4799-8252-5a163938fddc (opens source in a new tab)
Quetiapine label
Version not recorded · Effective date not recorded
Distribution Quetiapine is widely distributed throughout the body with an apparent volume of distribution of 10±4 L/kg.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:db48ec02-1119-f343-e053-2a95a90afb3b (opens source in a new tab)
Quetiapine label
Version not recorded · Effective date not recorded
Distribution Quetiapine is widely distributed throughout the body with an apparent volume of distribution of 10±4 L/kg.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:1618989e-2e6b-49ff-81b5-cf80d1dcfab4 (opens source in a new tab)
Quetiapine label
Version not recorded · Effective date not recorded
Distribution Quetiapine is widely distributed throughout the body with an apparent volume of distribution of 10±4 L/kg.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:6efc2886-7dcc-4dac-a212-76078a7efaa7 (opens source in a new tab)
Quetiapine label
Version not recorded · Effective date not recorded
Distribution Quetiapine is widely distributed throughout the body with an apparent volume of distribution of 10±4 L/kg.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:3622cbd4-d7cb-57d4-e063-6294a90a5f24 (opens source in a new tab)
Quetiapine label
Version not recorded · Effective date not recorded
Distribution Quetiapine is widely distributed throughout the body with an apparent volume of distribution of 10±4 L/kg.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:44e9b338-b163-bee7-e063-6394a90a1338 (opens source in a new tab)
Quetiapine label
Version not recorded · Effective date not recorded
Distribution Quetiapine is widely distributed throughout the body with an apparent volume of distribution of 10±4 L/kg.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:8923c441-c9aa-4b30-89d7-dbaaa7f66656 (opens source in a new tab)
Quetiapine label
Version not recorded · Effective date not recorded
Distribution Quetiapine is widely distributed throughout the body with an apparent volume of distribution of 10±4 L/kg.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:531cbe20-dff2-4983-9788-4543079f83ff (opens source in a new tab)
Quetiapine label
Version not recorded · Effective date not recorded
Distribution Quetiapine is widely distributed throughout the body with an apparent volume of distribution of 10±4 L/kg.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:b0cce89c-0e84-4f60-8e50-0e26c41c2613 (opens source in a new tab)
Quetiapine label
Version not recorded · Effective date not recorded
Distribution Quetiapine is widely distributed throughout the body with an apparent volume of distribution of 10±4 L/kg.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:f0ad842c-a0c2-4855-a55b-353b5338980f (opens source in a new tab)
Quetiapine label
Version not recorded · Effective date not recorded
Distribution Quetiapine is widely distributed throughout the body with an apparent volume of distribution of 10±4 L/kg.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:5074c897-bcf9-7497-e063-6394a90aa733 (opens source in a new tab)
Quetiapine label
Version not recorded · Effective date not recorded
Distribution Quetiapine is widely distributed throughout the body with an apparent volume of distribution of 10±4 L/kg.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:533154bb-a596-c88b-e063-6294a90a8956 (opens source in a new tab)
Quetiapine label
Version not recorded · Effective date not recorded
Distribution Quetiapine is widely distributed throughout the body with an apparent volume of distribution of 10±4 L/kg.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:ea9b9ed1-4be0-4dc0-b1dd-239caff5253e (opens source in a new tab)
Quetiapine label
Version not recorded · Effective date not recorded
Distribution Quetiapine is widely distributed throughout the body with an apparent volume of distribution of 10±4 L/kg.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:3112a006-1c61-47f2-84f5-9a7670d09c9b (opens source in a new tab)
Quetiapine label
Version not recorded · Effective date not recorded
Distribution Quetiapine is widely distributed throughout the body with an apparent volume of distribution of 10±4 L/kg.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:3eed13b8-7464-3720-e063-6294a90a1245 (opens source in a new tab)
Quetiapine label
Version not recorded · Effective date not recorded
Distribution Quetiapine is widely distributed throughout the body with an apparent volume of distribution of 10±4 L/kg.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:95156201-ed16-4806-98a7-d42acc902126 (opens source in a new tab)
Quetiapine label
Version not recorded · Effective date not recorded
Distribution Quetiapine is widely distributed throughout the body with an apparent volume of distribution of 10±4 L/kg.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:845159aa-1ac2-41b7-ac21-d4b03e43203b (opens source in a new tab)
Quetiapine label
Version not recorded · Effective date not recorded
Distribution Quetiapine is widely distributed throughout the body with an apparent volume of distribution of 10±4 L/kg.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:69275af7-1469-4405-a98e-e8b0f8d42dd9 (opens source in a new tab)
Quetiapine label
Version not recorded · Effective date not recorded
Distribution Quetiapine is widely distributed throughout the body with an apparent volume of distribution of 10±4 L/kg.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:61695b42-cf71-43e3-8b5d-788fd439489f (opens source in a new tab)
Quetiapine label
Version not recorded · Effective date not recorded
Distribution Quetiapine is widely distributed throughout the body with an apparent volume of distribution of 10±4 L/kg.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:b7aa0fce-1406-4665-a791-e30aed7b24ff (opens source in a new tab)
Quetiapine label
Version not recorded · Effective date not recorded
Distribution Quetiapine is widely distributed throughout the body with an apparent volume of distribution of 10±4 L/kg.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:6562eb60-0d70-4909-bd07-88d5c9241516 (opens source in a new tab)
Quetiapine label
Version not recorded · Effective date not recorded
Distribution Quetiapine is widely distributed throughout the body with an apparent volume of distribution of 10±4 L/kg.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:72111c36-c625-434f-9f16-7f25e0ff75f3 (opens source in a new tab)
Quetiapine label
Version not recorded · Effective date not recorded
Distribution Quetiapine is widely distributed throughout the body with an apparent volume of distribution of 10±4 L/kg.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:4e1e5249-1cb7-4cc2-ad5a-cdeeee2f494f (opens source in a new tab)
Quetiapine label
Version not recorded · Effective date not recorded
Distribution Quetiapine is widely distributed throughout the body with an apparent volume of distribution of 10±4 L/kg.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:d3dcfb51-e67d-44dc-9186-4729f6414bf1 (opens source in a new tab)
Quetiapine label
Version not recorded · Effective date not recorded
Distribution Quetiapine is widely distributed throughout the body with an apparent volume of distribution of 10±4 L/kg.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:b90390d8-6ebc-48b3-8b4d-6a3ff7d19ef6 (opens source in a new tab)
Quetiapine label
Version not recorded · Effective date not recorded
Distribution Quetiapine is widely distributed throughout the body with an apparent volume of distribution of 10±4 L/kg.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:070faf07-0ce7-4354-8643-9d222b72ecad (opens source in a new tab)
Quetiapine label
Version not recorded · Effective date not recorded
Distribution Quetiapine is widely distributed throughout the body with an apparent volume of distribution of 10±4 L/kg.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:3624100f-6e3f-a2ad-e063-6294a90a0fc0 (opens source in a new tab)
Quetiapine label
Version not recorded · Effective date not recorded
Distribution Quetiapine is widely distributed throughout the body with an apparent volume of distribution of 10±4 L/kg.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:717b55c4-a23f-4d74-8023-0f4e14d89ec8 (opens source in a new tab)
Quetiapine label
Version not recorded · Effective date not recorded
Distribution Quetiapine is widely distributed throughout the body with an apparent volume of distribution of 10±4 L/kg.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:74e09734-26cb-42fe-b9a3-79cc10505e0b (opens source in a new tab)
Quetiapine label
Version not recorded · Effective date not recorded
Distribution Quetiapine is widely distributed throughout the body with an apparent volume of distribution of 10±4 L/kg.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:951a098a-d905-4723-89e1-71bf1551dcb6 (opens source in a new tab)
Quetiapine label
Version not recorded · Effective date not recorded
Distribution Quetiapine is widely distributed throughout the body with an apparent volume of distribution of 10±4 L/kg.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:7a090720-fd90-4976-9aa2-41812106eb70 (opens source in a new tab)
Quetiapine label
Version not recorded · Effective date not recorded
Distribution Quetiapine is widely distributed throughout the body with an apparent volume of distribution of 10±4 L/kg.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:d2a76aed-a0b8-33f0-e053-2a95a90add0f (opens source in a new tab)
Quetiapine label
Version not recorded · Effective date not recorded
Distribution Quetiapine is widely distributed throughout the body with an apparent volume of distribution of 10±4 L/kg.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:b78b4e12-8ec4-470d-9bb5-665b5af328f5 (opens source in a new tab)
Quetiapine label
Version not recorded · Effective date not recorded
Distribution Quetiapine is widely distributed throughout the body with an apparent volume of distribution of 10±4 L/kg.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:01261008-5f42-4844-8a65-d4545a67a309 (opens source in a new tab)
Quetiapine label
Version not recorded · Effective date not recorded
Distribution Quetiapine is widely distributed throughout the body with an apparent volume of distribution of 10±4 L/kg.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:471d8e2d-4be6-6180-e063-6394a90ac721 (opens source in a new tab)
Quetiapine label
Version not recorded · Effective date not recorded
Distribution Quetiapine is widely distributed throughout the body with an apparent volume of distribution of 10±4 L/kg.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:42bd7dd3-9f81-4d8b-bce9-302e5559da2f (opens source in a new tab)
Quetiapine label
Version not recorded · Effective date not recorded
Distribution Quetiapine is widely distributed throughout the body with an apparent volume of distribution of 10±4 L/kg.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:b84e1614-b077-4ea5-8d11-df68f2b926de (opens source in a new tab)
Quetiapine label
Version not recorded · Effective date not recorded
Distribution Quetiapine is widely distributed throughout the body with an apparent volume of distribution of 10±4 L/kg.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:4872793c-a7be-1b65-e063-6394a90a8b3a (opens source in a new tab)
Quetiapine label
Version not recorded · Effective date not recorded
Distribution Quetiapine is widely distributed throughout the body with an apparent volume of distribution of 10±4 L/kg.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:aa0d27fd-569a-4573-b45d-2de5f5a30294 (opens source in a new tab)
Quetiapine label
Version not recorded · Effective date not recorded
Distribution Quetiapine is widely distributed throughout the body with an apparent volume of distribution of 10±4 L/kg.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:995731f7-aace-4140-b699-d6e8975c7c83 (opens source in a new tab)
Quetiapine label
Version not recorded · Effective date not recorded
Distribution Quetiapine is widely distributed throughout the body with an apparent volume of distribution of 10±4 L/kg.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:94a81681-381e-4b3b-89ac-e86dcbe7f890 (opens source in a new tab)
Quetiapine label
Version not recorded · Effective date not recorded
Distribution Quetiapine is widely distributed throughout the body with an apparent volume of distribution of 10±4 L/kg.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:b02324b1-e7f0-4cbc-8778-5f7c4a5d194a (opens source in a new tab)
Quetiapine label
Version not recorded · Effective date not recorded
Distribution Quetiapine is widely distributed throughout the body with an apparent volume of distribution of 10±4 L/kg.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:c52a9bff-8a03-44f5-9128-799c7dca0467 (opens source in a new tab)
Quetiapine label
Version not recorded · Effective date not recorded
Distribution Quetiapine is widely distributed throughout the body with an apparent volume of distribution of 10±4 L/kg.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:695415b1-083d-4540-9f41-bde4b201f834 (opens source in a new tab)
Quetiapine label
Version not recorded · Effective date not recorded
Distribution Quetiapine is widely distributed throughout the body with an apparent volume of distribution of 10±4 L/kg.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:1cfc847b-0d8d-fc94-e063-6394a90a311f (opens source in a new tab)
Quetiapine label
Version not recorded · Effective date not recorded
Distribution Quetiapine is widely distributed throughout the body with an apparent volume of distribution of 10±4 L/kg.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:392dd5cf-4777-4985-b62b-7370134dee26 (opens source in a new tab)
Quetiapine label
Version not recorded · Effective date not recorded
Distribution Quetiapine is widely distributed throughout the body with an apparent volume of distribution of 10±4 L/kg.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:fdece055-aeb5-43d6-b730-54dd74bde304 (opens source in a new tab)
Quetiapine label
Version not recorded · Effective date not recorded
Distribution Quetiapine is widely distributed throughout the body with an apparent volume of distribution of 10±4 L/kg.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:2b387188-c2c1-4865-984c-341a358d1c6c (opens source in a new tab)
Quetiapine label
Version not recorded · Effective date not recorded
Distribution Quetiapine is widely distributed throughout the body with an apparent volume of distribution of 10±4 L/kg.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:271e9fb7-3c70-43fc-8279-5adf189f3c22 (opens source in a new tab)
Quetiapine label
Version not recorded · Effective date not recorded
Distribution: Quetiapine is widely distributed throughout the body with an apparent volume of distribution of 10±4 L/kg.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:04cd529c-198b-5b85-e063-6294a90a4684 (opens source in a new tab)
Quetiapine label
Version not recorded · Effective date not recorded
Distribution Quetiapine is widely distributed throughout the body with an apparent volume of distribution of 10±4 L/kg.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:55018271-1f8f-4683-afee-8203c3bd9acc (opens source in a new tab)
Quetiapine label
Version not recorded · Effective date not recorded
Distribution Quetiapine is widely distributed throughout the body with an apparent volume of distribution of 10±4 L/kg.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:ab959a35-d0ba-4f18-8f2e-6619d88b16e3 (opens source in a new tab)
Quetiapine label
Version not recorded · Effective date not recorded
Distribution Quetiapine is widely distributed throughout the body with an apparent volume of distribution of 10±4 L/kg.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:61b1230e-c0dc-46c6-a577-7d5dd2515eb7 (opens source in a new tab)
Quetiapine label
Version not recorded · Effective date not recorded
Distribution Quetiapine is widely distributed throughout the body with an apparent volume of distribution of 10±4 L/kg.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:9f927ae2-a0ae-4953-99ba-8de59ee5bfca (opens source in a new tab)
Quetiapine label
Version not recorded · Effective date not recorded
Distribution Quetiapine is widely distributed throughout the body with an apparent volume of distribution of 10±4 L/kg.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:90da6c48-3282-41dc-b4fa-75d33efa9fee (opens source in a new tab)
Quetiapine label
Version not recorded · Effective date not recorded
Distribution Quetiapine is widely distributed throughout the body with an apparent volume of distribution of 10±4 L/kg.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:58541ffd-58c3-49aa-ad90-7e91a3c0b7d6 (opens source in a new tab)
Quetiapine label
Version not recorded · Effective date not recorded
Distribution Quetiapine is widely distributed throughout the body with an apparent volume of distribution of 10±4 L/kg.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:0fdbe32f-d04a-5666-e063-6294a90a8e36 (opens source in a new tab)
Quetiapine label
Version not recorded · Effective date not recorded
Distribution Quetiapine is widely distributed throughout the body with an apparent volume of distribution of 10±4 L/kg.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:3624c430-2a17-a83a-e063-6394a90add93 (opens source in a new tab)
Quetiapine label
Version not recorded · Effective date not recorded
Distribution Quetiapine is widely distributed throughout the body with an apparent volume of distribution of 10±4 L/kg.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:e4ce9d50-9786-2233-e053-2a95a90a276f (opens source in a new tab)
Quetiapine label
Version not recorded · Effective date not recorded
Distribution Quetiapine is widely distributed throughout the body with an apparent volume of distribution of 10±4 L/kg.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:6fc9c8e2-6f34-aa43-e053-2a91aa0ac377 (opens source in a new tab)
Quetiapine label
Version not recorded · Effective date not recorded
Distribution: Quetiapine is widely distributed throughout the body with an apparent volume of distribution of 10±4 L/kg.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:5e4a84b1-fb8c-44d0-8213-51e43d71db69 (opens source in a new tab)
Quetiapine label
Version not recorded · Effective date not recorded
Distribution Quetiapine is widely distributed throughout the body with an apparent volume of distribution of 10±4 L/kg.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:f3c91d05-038b-40f4-8c1f-2910773ec567 (opens source in a new tab)
Quetiapine label
Version not recorded · Effective date not recorded
Distribution Quetiapine is widely distributed throughout the body with an apparent volume of distribution of 10±4 L/kg.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:da5c118f-404c-4453-aa10-a8656b1d7501 (opens source in a new tab)
Quetiapine label
Version not recorded · Effective date not recorded
Distribution Quetiapine is widely distributed throughout the body with an apparent volume of distribution of 10±4 L/kg.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:55f574bc-ec55-93e2-e063-6394a90a1d47 (opens source in a new tab)
Quetiapine label
Version not recorded · Effective date not recorded
Distribution Quetiapine is widely distributed throughout the body with an apparent volume of distribution of 10±4 L/kg.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:56052e5c-0b0b-c296-e063-6394a90a5ad6 (opens source in a new tab)
Quetiapine label
Version not recorded · Effective date not recorded
Distribution Quetiapine is widely distributed throughout the body with an apparent volume of distribution of 10±4 L/kg.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:3eb39b4e-4c79-43b9-a30e-b4221c0e2bd2 (opens source in a new tab)
Quetiapine label
Version not recorded · Effective date not recorded
Distribution Quetiapine is widely distributed throughout the body with an apparent volume of distribution of 10±4 L/kg.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:c6c454c4-3eae-48ae-bf17-5dccdb659141 (opens source in a new tab)
Quetiapine label
Version not recorded · Effective date not recorded
Distribution Quetiapine is widely distributed throughout the body with an apparent volume of distribution of 10±4 L/kg.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:8ae62aaf-f8c5-417f-baac-0098369ca322 (opens source in a new tab)
Quetiapine label
Version not recorded · Effective date not recorded
Distribution Quetiapine is widely distributed throughout the body with an apparent volume of distribution of 10±4 L/kg.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:a951cd63-d329-47c9-965a-582fa73a07c6 (opens source in a new tab)
Quetiapine label
Version not recorded · Effective date not recorded
Distribution Quetiapine is widely distributed throughout the body with an apparent volume of distribution of 10±4 L/kg.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:55a5671b-7771-0adf-e063-6294a90acfa6 (opens source in a new tab)
Quetiapine label
Version not recorded · Effective date not recorded
Distribution Quetiapine is widely distributed throughout the body with an apparent volume of distribution of 10±4 L/kg.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:41dbd5a5-4ae2-4ac1-8135-0fdac5c170b5 (opens source in a new tab)
Quetiapine label
Version not recorded · Effective date not recorded
Distribution Quetiapine is widely distributed throughout the body with an apparent volume of distribution of 10±4 L/kg.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:911bf26c-a89a-4ce1-8ff5-cfda03d0a482 (opens source in a new tab)
Quetiapine label
Version not recorded · Effective date not recorded
Distribution Quetiapine is widely distributed throughout the body with an apparent volume of distribution of 10±4 L/kg.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:9a024071-e620-48e8-9f22-d4cda5dc5ab1 (opens source in a new tab)
Quetiapine label
Version not recorded · Effective date not recorded
Distribution Quetiapine is widely distributed throughout the body with an apparent volume of distribution of 10±4 L/kg.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:293a9857-d138-4583-abc9-35b75660e324 (opens source in a new tab)
Quetiapine label
Version not recorded · Effective date not recorded
Distribution Quetiapine is widely distributed throughout the body with an apparent volume of distribution of 10±4 L/kg.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:07e4f3f4-42cb-4b22-bf8d-8c3279d26e97 (opens source in a new tab)
Quetiapine label
Version not recorded · Effective date not recorded
Distribution Quetiapine is widely distributed throughout the body with an apparent volume of distribution of 10±4 L/kg.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:35f6ad40-192a-4d1f-ace0-9fb69b9d984d (opens source in a new tab)
Quetiapine label
Version not recorded · Effective date not recorded
Distribution Quetiapine is widely distributed throughout the body with an apparent volume of distribution of 10±4 L/kg.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:45947f72-d870-4f6e-9e5f-38d6b324d5fe (opens source in a new tab)
Quetiapine label
Version not recorded · Effective date not recorded
Distribution Quetiapine is widely distributed throughout the body with an apparent volume of distribution of 10±4 L/kg.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:461523b5-8d12-9d96-e063-6394a90ad4c2 (opens source in a new tab)
Quetiapine label
Version not recorded · Effective date not recorded
Distribution Quetiapine is widely distributed throughout the body with an apparent volume of distribution of 10±4 L/kg.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:186c5cde-5066-4436-99ef-28049c12826b (opens source in a new tab)
Quetiapine label
Version not recorded · Effective date not recorded
Distribution Quetiapine is widely distributed throughout the body with an apparent volume of distribution of 10±4 L/kg.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:0584dda8-bc3c-48fe-1a90-79608f78e8a0 (opens source in a new tab)
Quetiapine label
Version not recorded · Effective date not recorded
Distribution Quetiapine is widely distributed throughout the body with an apparent volume of distribution of 10±4 L/kg.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:dd6b6088-943e-413b-9886-88dd9c622be4 (opens source in a new tab)
Quetiapine label
Version not recorded · Effective date not recorded
Distribution Quetiapine is widely distributed throughout the body with an apparent volume of distribution of 10±4 L/kg.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:03517f29-f270-4350-a57a-fbe1967b0096 (opens source in a new tab)
Quetiapine label
Version not recorded · Effective date not recorded
Distribution Quetiapine is widely distributed throughout the body with an apparent volume of distribution of 10±4 L/kg.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:35b2069e-209a-41ac-84e6-377d4f19be87 (opens source in a new tab)
Quetiapine label
Version not recorded · Effective date not recorded
Distribution Quetiapine is widely distributed throughout the body with an apparent volume of distribution of 10±4 L/kg.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:258eac65-69ed-404f-e063-6394a90a19ef (opens source in a new tab)
Quetiapine label
Version not recorded · Effective date not recorded
Distribution Quetiapine is widely distributed throughout the body with an apparent volume of distribution of 10±4 L/kg.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:f75a4d38-ea0e-4780-abf2-67672894a11b (opens source in a new tab)
Quetiapine label
Version not recorded · Effective date not recorded
Distribution Quetiapine is widely distributed throughout the body with an apparent volume of distribution of 10±4 L/kg.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:cb989abf-7d73-4ab9-a07f-a8c9de50389f (opens source in a new tab)
Quetiapine label
Version not recorded · Effective date not recorded
Distribution Quetiapine is widely distributed throughout the body with an apparent volume of distribution of 10±4 L/kg.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:a45d8b77-f13d-41c5-8d50-15152fc6f85c (opens source in a new tab)
Quetiapine label
Version not recorded · Effective date not recorded
Distribution Quetiapine is widely distributed throughout the body with an apparent volume of distribution of 10±4 L/kg.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:897184b1-de3c-4d59-91be-3069325fd5b2 (opens source in a new tab)
Quetiapine label
Version not recorded · Effective date not recorded
Distribution Quetiapine is widely distributed throughout the body with an apparent volume of distribution of 10±4 L/kg.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:ffe52b98-9872-48c1-90fd-8fcd37c3432f (opens source in a new tab)
Quetiapine label
Version not recorded · Effective date not recorded
Distribution Quetiapine is widely distributed throughout the body with an apparent volume of distribution of 10±4 L/kg.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:16f48034-b8c9-ab2b-e063-6294a90adf65 (opens source in a new tab)
Quetiapine label
Version not recorded · Effective date not recorded
Distribution Quetiapine is widely distributed throughout the body with an apparent volume of distribution of 10±4 L/kg.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:55f358e1-9458-b197-e063-6394a90a3f0e (opens source in a new tab)
Quetiapine label
Version not recorded · Effective date not recorded
Distribution Quetiapine is widely distributed throughout the body with an apparent volume of distribution of 10±4 L/kg.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:3085f68d-e83c-4f59-b058-8bdae7f4e537 (opens source in a new tab)
Quetiapine label
Version not recorded · Effective date not recorded
Distribution Quetiapine is widely distributed throughout the body with an apparent volume of distribution of 10±4 L/kg.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:b8864cb9-1c6a-4e36-9893-eb1403ee8745 (opens source in a new tab)
Quetiapine label
Version not recorded · Effective date not recorded
Distribution Quetiapine is widely distributed throughout the body with an apparent volume of distribution of 10±4 L/kg.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:d51c5bf6-950d-493b-be55-de575c5ef2e7 (opens source in a new tab)
Quetiapine label
Version not recorded · Effective date not recorded
Distribution Quetiapine is widely distributed throughout the body with an apparent volume of distribution of 10±4 L/kg.
Projected row 1283
- Medicine slug
- quinapril
- Compared field
- halfLife
- Comparison state
- agree
- Reason codes
- COMPATIBLE_VALUES_OVERLAP
- Documents examined
- 15
- Source count
- 15
- Agreement rate
- 1
- Recorded readings
3 hours
- Numeric value
- 3
- Unit
- hours
- Source records
- 15
Population and context: Unknown: population and formulation context were not structurally extracted from this source sentence.
Show all 15 source records
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:2efb2ede-a49b-4e3e-9c93-4c202f67211f (opens source in a new tab)
Quinapril label
Version not recorded · Effective date not recorded
Following multiple oral dosing of quinapril, there is an effective accumulation half-life of quinaprilat of approximately 3 hours, and peak plasma quinaprilat concentrations are observed approximately 2 hours post-dose.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:da84cb14-a9dd-4df0-a7e5-d5fbd84ac6da (opens source in a new tab)
Quinapril label
Version not recorded · Effective date not recorded
Following multiple oral dosing of quinapril, there is an effective accumulation half-life of quinaprilat of approximately 3 hours, and peak plasma quinaprilat concentrations are observed approximately 2 hours post-dose.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:1aafcf35-46cb-4a6f-81d4-821c599bdb71 (opens source in a new tab)
Quinapril label
Version not recorded · Effective date not recorded
Following multiple oral dosing of quinapril, there is an effective accumulation half-life of quinaprilat of approximately 3 hours, and peak plasma quinaprilat concentrations are observed approximately 2 hours post-dose.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:da562e3b-4411-e750-e053-2a95a90ad7e5 (opens source in a new tab)
Quinapril label
Version not recorded · Effective date not recorded
Following multiple oral dosing of quinapril, there is an effective accumulation half-life of quinaprilat of approximately 3 hours, and peak plasma quinaprilat concentrations are observed approximately 2 hours post-dose.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:dbc43dbd-94aa-40e2-a9ea-766110cc8687 (opens source in a new tab)
Quinapril label
Version not recorded · Effective date not recorded
Following multiple oral dosing of quinapril hydrochloride, there is an effective accumulation half-life of quinaprilat of approximately 3 hours, and peak plasma quinaprilat concentrations are observed approximately 2 hours post-dose.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:fb069caa-14d0-4f76-b662-6145fb4cc276 (opens source in a new tab)
Quinapril label
Version not recorded · Effective date not recorded
Following multiple oral dosing of quinapril, there is an effective accumulation half-life of quinaprilat of approximately 3 hours, and peak plasma quinaprilat concentrations are observed approximately 2 hours post-dose.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:a6cf2ffd-cf94-4f1c-a12e-ce0e93a6304d (opens source in a new tab)
Quinapril label
Version not recorded · Effective date not recorded
Following multiple oral dosing of quinapril, there is an effective accumulation half-life of quinaprilat of approximately 3 hours, and peak plasma quinaprilat concentrations are observed approximately 2 hours post-dose.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:42e4f9dd-6032-4257-bd0f-8e9b71027f03 (opens source in a new tab)
Quinapril label
Version not recorded · Effective date not recorded
Following multiple oral dosing of quinapril hydrochloride, there is an effective accumulation half-life of quinaprilat of approximately 3 hours, and peak plasma quinaprilat concentrations are observed approximately 2 hours post-dose.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:93e6e668-5306-4f26-81d8-cbc3a7a5e787 (opens source in a new tab)
Quinapril label
Version not recorded · Effective date not recorded
Following multiple oral dosing of quinapril hydrochloride, there is an effective accumulation half-life of quinaprilat of approximately 3 hours, and peak plasma quinaprilat concentrations are observed approximately 2 hours post-dose.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:8ded0773-3aec-4e89-9836-d22a5a84abf0 (opens source in a new tab)
Quinapril label
Version not recorded · Effective date not recorded
Following multiple oral dosing of quinapril, there is an effective accumulation half-life of quinaprilat of approximately 3 hours, and peak plasma quinaprilat concentrations are observed approximately 2 hours post-dose.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:1b5809a8-873d-44cb-af59-e0d8fc81b385 (opens source in a new tab)
Quinapril label
Version not recorded · Effective date not recorded
Following multiple oral dosing of quinapril, there is an effective accumulation half-life of quinaprilat of approximately 3 hours, and peak plasma quinaprilat concentrations are observed approximately 2 hours post-dose.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:f33dbbb1-1a4a-42b0-a5c5-3ac905823206 (opens source in a new tab)
Quinapril label
Version not recorded · Effective date not recorded
Following multiple oral dosing of quinapril hydrochloride, there is an effective accumulation half-life of quinaprilat of approximately 3 hours, and peak plasma quinaprilat concentrations are observed approximately 2 hours post-dose.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:cd46691d-5593-4a9f-a937-999c6803e312 (opens source in a new tab)
Quinapril label
Version not recorded · Effective date not recorded
Following multiple oral dosing of quinapril, there is an effective accumulation half-life of quinaprilat of approximately 3 hours, and peak plasma quinaprilat concentrations are observed approximately 2 hours post-dose.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:a62d0ed3-8fcc-45fb-9246-b57b08a11f60 (opens source in a new tab)
Quinapril label
Version not recorded · Effective date not recorded
Following multiple oral dosing of quinapril hydrochloride, there is an effective accumulation half-life of quinaprilat of approximately 3 hours, and peak plasma quinaprilat concentrations are observed approximately 2 hours post-dose.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:e6d36e1e-8e35-4d06-83dc-45e0456365fd (opens source in a new tab)
Quinapril label
Version not recorded · Effective date not recorded
Following multiple oral dosing of quinapril, there is an effective accumulation half-life of quinaprilat of approximately 3 hours, and peak plasma quinaprilat concentrations are observed approximately 2 hours post-dose.
Projected row 1284
- Medicine slug
- quinine-sulphate
- Compared field
- bioavailability
- Comparison state
- insufficient_context
- Reason codes
- STRUCTURED_CONTEXT_MISSING
- Documents examined
- 10
- Source count
- 4
- Agreement rate
- 0.75
- Recorded readings
76 to 88%
- Numeric value
- 76
- Unit
- %
- Source records
- 3
Population and context: Unknown: population and formulation context were not structurally extracted from this source sentence.
Show all 3 source records
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:1f32f05c-a215-40be-b951-e41a7b54a8a0 (opens source in a new tab)
Quinine Sulphate label
Version not recorded · Effective date not recorded
The maximum mean (95% upper confidence bound) difference in QRS from placebo after baseline-correction was 11.5 (13.3) ms. [see WARNINGS AND PRECAUTIONS ( 5.3 )] . 12.3 Pharmacokinetics Absorption The oral bioavailability of quinine is 76 to 88% in healthy adults.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:b2f73c64-b92c-49bf-ad39-e32ac83e4d3d (opens source in a new tab)
Quinine Sulphate label
Version not recorded · Effective date not recorded
12.3 Pharmacokinetics Absorption The oral bioavailability of quinine is 76 to 88% in healthy adults.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:e782283e-2608-4fd6-a8b2-6c30b9d5d3b0 (opens source in a new tab)
Quinine Sulphate label
Version not recorded · Effective date not recorded
12.3 Pharmacokinetics Absorption The oral bioavailability of quinine is 76 to 88% in healthy adults.
76%
- Numeric value
- 76
- Unit
- %
- Source records
- 1
Population and context: Unknown: population and formulation context were not structurally extracted from this source sentence.
Show all 1 source records
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:f567d5c7-ea5d-49a7-a035-b47208135f73 (opens source in a new tab)
Quinine Sulphate label
Version not recorded · Effective date not recorded
The maximum mean (95% upper confidence bound) difference in QRS from placebo after baseline-correction was 11.5 (13.3) ms [see Warnings and Precautions (5.4) ] . 12.3 Pharmacokinetics Absorption The oral bioavailability of quinine is 76% to 88% in healthy adults.
Projected row 1285
- Medicine slug
- quinine-sulphate
- Compared field
- halfLife
- Comparison state
- agree
- Reason codes
- COMPATIBLE_VALUES_OVERLAP
- Documents examined
- 10
- Source count
- 4
- Agreement rate
- 1
- Recorded readings
9.7 to 12.5 hours
- Numeric value
- 9.7
- Unit
- hours
- Source records
- 4
Population and context: Unknown: population and formulation context were not structurally extracted from this source sentence.
Show all 4 source records
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:1f32f05c-a215-40be-b951-e41a7b54a8a0 (opens source in a new tab)
Quinine Sulphate label
Version not recorded · Effective date not recorded
In various published studies, healthy subjects who received a single oral 600 mg dose of quinine sulfate exhibited a mean plasma clearance ranging from 0.08 to 0.47 L/h/kg (median value: 0.17 L/h/kg) with a mean plasma elimination half-life of 9.7 to 12.5 hours.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:b2f73c64-b92c-49bf-ad39-e32ac83e4d3d (opens source in a new tab)
Quinine Sulphate label
Version not recorded · Effective date not recorded
In various published studies, healthy subjects who received a single oral 600 mg dose of quinine sulfate exhibited a mean plasma clearance ranging from 0.08 to 0.47 L/h/kg (median value: 0.17 L/h/kg) with a mean plasma elimination half-life of 9.7 to 12.5 hours.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:e782283e-2608-4fd6-a8b2-6c30b9d5d3b0 (opens source in a new tab)
Quinine Sulphate label
Version not recorded · Effective date not recorded
In various published studies, healthy subjects who received a single oral 600 mg dose of quinine sulfate exhibited a mean plasma clearance ranging from 0.08 to 0.47 L/h/kg (median value: 0.17 L/h/kg) with a mean plasma elimination half-life of 9.7 to 12.5 hours.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:f567d5c7-ea5d-49a7-a035-b47208135f73 (opens source in a new tab)
Quinine Sulphate label
Version not recorded · Effective date not recorded
In various published studies, healthy subjects who received a single oral 600 mg dose of quinine sulfate exhibited a mean plasma clearance ranging from 0.08 L/h/kg to 0.47 L/h/kg (median value: 0.17 L/h/kg) with a mean plasma elimination half-life of 9.7 to 12.5 hours.
Projected row 1286
- Medicine slug
- quinine-sulphate
- Compared field
- proteinBinding
- Comparison state
- insufficient_context
- Reason codes
- STRUCTURED_CONTEXT_MISSING
- Documents examined
- 10
- Source count
- 4
- Agreement rate
- 0.75
- Recorded readings
78 to 95%
- Numeric value
- 78
- Unit
- %
- Source records
- 3
Population and context: Unknown: population and formulation context were not structurally extracted from this source sentence.
Show all 3 source records
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:1f32f05c-a215-40be-b951-e41a7b54a8a0 (opens source in a new tab)
Quinine Sulphate label
Version not recorded · Effective date not recorded
During active malarial infection, protein binding of quinine is increased to 78 to 95%, corresponding to the increase in α 1 -acid glycoprotein that occurs with malaria infection.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:b2f73c64-b92c-49bf-ad39-e32ac83e4d3d (opens source in a new tab)
Quinine Sulphate label
Version not recorded · Effective date not recorded
During active malarial infection, protein binding of quinine is increased to 78 to 95%, corresponding to the increase in α1-acid glycoprotein that occurs with malaria infection.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:e782283e-2608-4fd6-a8b2-6c30b9d5d3b0 (opens source in a new tab)
Quinine Sulphate label
Version not recorded · Effective date not recorded
During active malarial infection, protein binding of quinine is increased to 78 to 95%, corresponding to the increase in α 1 -acid glycoprotein that occurs with malaria infection.
78%
- Numeric value
- 78
- Unit
- %
- Source records
- 1
Population and context: Unknown: population and formulation context were not structurally extracted from this source sentence.
Show all 1 source records
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:f567d5c7-ea5d-49a7-a035-b47208135f73 (opens source in a new tab)
Quinine Sulphate label
Version not recorded · Effective date not recorded
During active malarial infection, protein binding of quinine is increased to 78% to 95%, corresponding to the increase in α1-acid glycoprotein that occurs with malaria infection.
Projected row 1287
- Medicine slug
- quinine-sulphate
- Compared field
- tMax
- Comparison state
- agree
- Reason codes
- COMPATIBLE_VALUES_OVERLAP
- Documents examined
- 10
- Source count
- 4
- Agreement rate
- 1
- Recorded readings
4.0 hours
- Numeric value
- 4
- Unit
- hours
- Source records
- 4
Population and context: Unknown: population and formulation context were not structurally extracted from this source sentence.
Show all 4 source records
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:1f32f05c-a215-40be-b951-e41a7b54a8a0 (opens source in a new tab)
Quinine Sulphate label
Version not recorded · Effective date not recorded
When a single oral 324 mg capsule of quinine sulfate was administered to healthy subjects (N=26) with a standardized high-fat breakfast, the mean T max of quinine was prolonged to about 4.0 hours, but the mean C max and AUC 0-24h were similar to those achieved when quinine sulfate capsule was given under fasted conditions [see DOSAGE AND ADMINISTRATION ( 2.1 )] .
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:b2f73c64-b92c-49bf-ad39-e32ac83e4d3d (opens source in a new tab)
Quinine Sulphate label
Version not recorded · Effective date not recorded
When a single oral 324 mg capsule of Quinine Sulfate was administered to healthy subjects (N=26) with a standardized high-fat breakfast, the mean T max of quinine was prolonged to about 4.0 hours, but the mean C max and AUC 0-24h were similar to those achieved when Quinine Sulfate capsule was given under fasted conditions [ see Dosage and Administration (2.1) ].
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:e782283e-2608-4fd6-a8b2-6c30b9d5d3b0 (opens source in a new tab)
Quinine Sulphate label
Version not recorded · Effective date not recorded
When a single oral 324 mg capsule of quinine sulfate was administered to healthy subjects (N=26) with a standardized high-fat breakfast, the mean T max of quinine was prolonged to about 4.0 hours, but the mean C max and AUC 0-24h were similar to those achieved when quinine sulfate capsule was given under fasted conditions [ see Dosage and Administration ( 2.1 ) ].
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:f567d5c7-ea5d-49a7-a035-b47208135f73 (opens source in a new tab)
Quinine Sulphate label
Version not recorded · Effective date not recorded
When a single oral 324 mg capsule of quinine sulfate was administered to healthy subjects (N=26) with a standardized high-fat breakfast, the mean T max of quinine was prolonged to about 4.0 hours, but the mean C max and AUC 0-24h were similar to those achieved when quinine sulfate capsule was given under fasted conditions [see Dosage and Administration (2.1) ] .
Projected row 1288
- Medicine slug
- rabeprazole
- Compared field
- halfLife
- Comparison state
- agree
- Reason codes
- COMPATIBLE_VALUES_OVERLAP
- Documents examined
- 37
- Source count
- 37
- Agreement rate
- 1
- Recorded readings
1 to 2 hours
- Numeric value
- 1
- Unit
- hours
- Source records
- 37
Population and context: Unknown: population and formulation context were not structurally extracted from this source sentence.
Show all 37 source records
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:4ded337a-31b8-47c3-b5ab-33a785afb7d8 (opens source in a new tab)
Rabeprazole label
Version not recorded · Effective date not recorded
This relatively prolonged pharmacodynamic action compared to the short pharmacokinetic half-life (1 to 2 hours) reflects the sustained inactivation of the H + , K + ATPase.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:0e2e00fa-c4c5-4de7-adf9-cd9786b97016 (opens source in a new tab)
Rabeprazole label
Version not recorded · Effective date not recorded
This relatively prolonged pharmacodynamic action compared to the short pharmacokinetic half-life (1 to 2 hours) reflects the sustained inactivation of the H + , K + ATPase.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:87231460-8b1e-b995-e053-2a91aa0a6c43 (opens source in a new tab)
Rabeprazole label
Version not recorded · Effective date not recorded
This relatively prolonged pharmacodynamic action compared to the short pharmacokinetic half-life (1 to 2 hours) reflects the sustained inactivation of the H + , K + ATPase.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:c5c43222-d167-4152-b5c7-84b55920a7ce (opens source in a new tab)
Rabeprazole label
Version not recorded · Effective date not recorded
This relatively prolonged pharmacodynamic action compared to the short pharmacokinetic half-life (1 to 2 hours) reflects the sustained inactivation of the H + , K + ATPase.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:3b6a25c2-fb61-4c86-9988-c6ffac7939c4 (opens source in a new tab)
Rabeprazole label
Version not recorded · Effective date not recorded
This relatively prolonged pharmacodynamic action compared to the short pharmacokinetic half-life (1 to 2 hours) reflects the sustained inactivation of the H + , K + ATPase.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:9237eaa4-8eec-fb2a-e053-2995a90ab6c0 (opens source in a new tab)
Rabeprazole label
Version not recorded · Effective date not recorded
This relatively prolonged pharmacodynamic action compared to the short pharmacokinetic half-life (1 to 2 hours) reflects the sustained inactivation of the H + , K + ATPase.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:63e0b7ca-6b2d-42a9-b9d4-4523b8a20425 (opens source in a new tab)
Rabeprazole label
Version not recorded · Effective date not recorded
This relatively prolonged pharmacodynamic action compared to the short pharmacokinetic half-life (1 to 2 hours) reflects the sustained inactivation of the H + , K + ATPase.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:d11c3211-b4d4-4893-8c1c-b8fb6d0a0b89 (opens source in a new tab)
Rabeprazole label
Version not recorded · Effective date not recorded
This relatively prolonged pharmacodynamic action compared to the short pharmacokinetic half-life (1 to 2 hours) reflects the sustained inactivation of the H + , K + ATPase.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:12eaf996-db61-41d6-82e1-fa6196435603 (opens source in a new tab)
Rabeprazole label
Version not recorded · Effective date not recorded
This relatively prolonged pharmacodynamic action compared to the short pharmacokinetic half-life (1 to 2 hours) reflects the sustained inactivation of the H + , K + ATPase.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:b1b7def0-834f-37f5-e053-2a95a90ade1f (opens source in a new tab)
Rabeprazole label
Version not recorded · Effective date not recorded
This relatively prolonged pharmacodynamic action compared to the short pharmacokinetic half-life (1 to 2 hours) reflects the sustained inactivation of the H+, K+ATPase.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:350c20b0-1879-d4cb-e063-6294a90a37f2 (opens source in a new tab)
Rabeprazole label
Version not recorded · Effective date not recorded
This relatively prolonged pharmacodynamic action compared to the short pharmacokinetic half-life (1 to 2 hours) reflects the sustained inactivation of the H + , K + ATPase.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:b354053c-cb83-79c6-e053-2a95a90afdbe (opens source in a new tab)
Rabeprazole label
Version not recorded · Effective date not recorded
This relatively prolonged pharmacodynamic action compared to the short pharmacokinetic half-life (1 to 2 hours) reflects the sustained inactivation of the H+, K+ATPase.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:14412af6-e99c-4264-bc34-28a6f139f252 (opens source in a new tab)
Rabeprazole label
Version not recorded · Effective date not recorded
This relatively prolonged pharmacodynamic action compared to the short pharmacokinetic half-life (1-2 hours) reflects the sustained inactivation of the H + , K + ATPase.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:1855ccab-c377-4962-9225-3c5adc62e2bd (opens source in a new tab)
Rabeprazole label
Version not recorded · Effective date not recorded
This relatively prolonged pharmacodynamic action compared to the short pharmacokinetic half-life (1 to 2 hours) reflects the sustained inactivation of the H + , K + ATPase.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:04e88b86-e1dd-4c56-8359-45fbcc161f7d (opens source in a new tab)
Rabeprazole label
Version not recorded · Effective date not recorded
This relatively prolonged pharmacodynamic action compared to the short pharmacokinetic half-life (1 to 2 hours) reflects the sustained inactivation of the H + , K + ATPase.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:68b7a793-f22b-4609-a640-94fdec703d93 (opens source in a new tab)
Rabeprazole label
Version not recorded · Effective date not recorded
This relatively prolonged pharmacodynamic action compared to the short pharmacokinetic half-life (1 to 2 hours) reflects the sustained inactivation of the H + , K + ATPase.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:9881dbb2-1ce2-4737-989f-b26720791ca5 (opens source in a new tab)
Rabeprazole label
Version not recorded · Effective date not recorded
This relatively prolonged pharmacodynamic action compared to the short pharmacokinetic half-life (1 to 2 hours) reflects the sustained inactivation of the H + , K + ATPase.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:3a674849-b2f6-5f43-e063-6294a90a9e20 (opens source in a new tab)
Rabeprazole label
Version not recorded · Effective date not recorded
This relatively prolonged pharmacodynamic action compared to the short pharmacokinetic half-life (1 to 2 hours) reflects the sustained inactivation of the H + , K + ATPase.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:4e8b9858-23a1-4363-b26f-ee6b9ff7ebf9 (opens source in a new tab)
Rabeprazole label
Version not recorded · Effective date not recorded
This relatively prolonged pharmacodynamic action compared to the short pharmacokinetic half-life (1 to 2 hours) reflects the sustained inactivation of the H + , K + ATPase.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:0863f340-4c7e-379a-e063-6394a90a758d (opens source in a new tab)
Rabeprazole label
Version not recorded · Effective date not recorded
This relatively prolonged pharmacodynamic action compared to the short pharmacokinetic half-life (1 to 2 hours) reflects the sustained inactivation of the H + , K + ATPase.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:8d8c1a72-b4c4-4699-b9c3-3a39a9df44f2 (opens source in a new tab)
Rabeprazole label
Version not recorded · Effective date not recorded
This relatively prolonged pharmacodynamic action compared to the short pharmacokinetic half-life (1 to 2 hours) reflects the sustained inactivation of the H + , K + ATPase.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:b1a12c83-74ab-febc-e053-2a95a90a1441 (opens source in a new tab)
Rabeprazole label
Version not recorded · Effective date not recorded
This relatively prolonged pharmacodynamic action compared to the short pharmacokinetic half-life (1 to 2 hours) reflects the sustained inactivation of the H + , K + ATPase.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:d1444508-fe40-4f68-8350-52f13399e38a (opens source in a new tab)
Rabeprazole label
Version not recorded · Effective date not recorded
This relatively prolonged pharmacodynamic action compared to the short pharmacokinetic half-life (1-2 hours) reflects the sustained inactivation of the H + , K + ATPase.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:7f7d68f0-972b-4315-b712-0bb8a84c85cc (opens source in a new tab)
Rabeprazole label
Version not recorded · Effective date not recorded
This relatively prolonged pharmacodynamic action compared to the short pharmacokinetic half-life (1 to 2 hours) reflects the sustained inactivation of the H + , K + ATPase.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:26f8c3bc-4402-e92c-e063-6294a90a9ad7 (opens source in a new tab)
Rabeprazole label
Version not recorded · Effective date not recorded
This relatively prolonged pharmacodynamic action compared to the short pharmacokinetic half-life (1 to 2 hours) reflects the sustained inactivation of the H + , K + ATPase.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:1eb38279-0237-4967-be7a-c53a826c1138 (opens source in a new tab)
Rabeprazole label
Version not recorded · Effective date not recorded
This relatively prolonged pharmacodynamic action compared to the short pharmacokinetic half-life (1 to 2 hours) reflects the sustained inactivation of the H + , K + ATPase.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:bdad0b58-495e-2352-e053-2a95a90a3198 (opens source in a new tab)
Rabeprazole label
Version not recorded · Effective date not recorded
This relatively prolonged pharmacodynamic action compared to the short pharmacokinetic half-life (1 to 2 hours) reflects the sustained inactivation of the H+, K+ATPase.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:4582d443-f1be-4f94-85da-49aa603f54e4 (opens source in a new tab)
Rabeprazole label
Version not recorded · Effective date not recorded
This relatively prolonged pharmacodynamic action compared to the short pharmacokinetic half-life (1 to 2 hours) reflects the sustained inactivation of the H + , K + ATPase.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:ac9266ed-a9b2-4e77-8607-393b5dcdd2b6 (opens source in a new tab)
Rabeprazole label
Version not recorded · Effective date not recorded
This relatively prolonged pharmacodynamic action compared to the short pharmacokinetic half-life (1 to 2 hours) reflects the sustained inactivation of the H + , K + ATPase.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:bafff1ac-02fb-4726-b2d7-6e099ae981cb (opens source in a new tab)
Rabeprazole label
Version not recorded · Effective date not recorded
This relatively prolonged pharmacodynamic action compared to the short pharmacokinetic half-life (1 to 2 hours) reflects the sustained inactivation of the H + , K + ATPase.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:e6350638-99b0-474d-be75-ae2a3e1af2cf (opens source in a new tab)
Rabeprazole label
Version not recorded · Effective date not recorded
This relatively prolonged pharmacodynamic action compared to the short pharmacokinetic half-life (1 to 2 hours) reflects the sustained inactivation of the H + , K + ATPase.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:0f5eb1b4-ad4b-4782-8d3d-cd33f9c5be7d (opens source in a new tab)
Rabeprazole label
Version not recorded · Effective date not recorded
This relatively prolonged pharmacodynamic action compared to the short pharmacokinetic half-life (1 to 2 hours) reflects the sustained inactivation of the H + , K + ATPase.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:45092108-7c4a-48f9-8222-ca8612e82189 (opens source in a new tab)
Rabeprazole label
Version not recorded · Effective date not recorded
This relatively prolonged pharmacodynamic action compared to the short pharmacokinetic half-life (1 to 2 hours) reflects the sustained inactivation of the H + , K + ATPase.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:c212c9d5-32d3-3c5f-e053-2a95a90af88b (opens source in a new tab)
Rabeprazole label
Version not recorded · Effective date not recorded
This relatively prolonged pharmacodynamic action compared to the short pharmacokinetic half-life (1 to 2 hours) reflects the sustained inactivation of the H + , K + ATPase.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:b35f376a-f2a4-4eb9-80ac-9c20ceb2f0bf (opens source in a new tab)
Rabeprazole label
Version not recorded · Effective date not recorded
This relatively prolonged pharmacodynamic action compared to the short pharmacokinetic half-life (1 to 2 hours) reflects the sustained inactivation of the H + , K + ATPase.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:9ea2552c-873c-4ab2-84b0-dd54e84e4eee (opens source in a new tab)
Rabeprazole label
Version not recorded · Effective date not recorded
This relatively prolonged pharmacodynamic action compared to the short pharmacokinetic half-life (1 to 2 hours) reflects the sustained inactivation of the H + , K + ATPase.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:951caefe-6e18-48ff-9567-beb545b09c25 (opens source in a new tab)
Rabeprazole label
Version not recorded · Effective date not recorded
This relatively prolonged pharmacodynamic action compared to the short pharmacokinetic half-life (1 to 2 hours) reflects the sustained inactivation of the H + , K + ATPase.
Projected row 1289
- Medicine slug
- rabeprazole
- Compared field
- tMax
- Comparison state
- insufficient_context
- Reason codes
- STRUCTURED_CONTEXT_MISSING
- Documents examined
- 37
- Source count
- 37
- Agreement rate
- 0.972973
- Recorded readings
2 to 5 hours
- Numeric value
- 2
- Unit
- hours
- Source records
- 36
Population and context: Unknown: population and formulation context were not structurally extracted from this source sentence.
Show all 36 source records
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:4ded337a-31b8-47c3-b5ab-33a785afb7d8 (opens source in a new tab)
Rabeprazole label
Version not recorded · Effective date not recorded
12.3 Pharmacokinetics After oral administration of 20 mg rabeprazole sodium delayed-release tablets, peak plasma concentrations (C max ) of rabeprazole occur over a range of 2 to 5 hours (T max ).
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:0e2e00fa-c4c5-4de7-adf9-cd9786b97016 (opens source in a new tab)
Rabeprazole label
Version not recorded · Effective date not recorded
12.3 Pharmacokinetics After oral administration of 20 mg Rabeprazole Sodium delayed-release tablets, peak plasma concentrations (C max ) of rabeprazole occur over a range of 2 to 5 hours (T max ).
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:87231460-8b1e-b995-e053-2a91aa0a6c43 (opens source in a new tab)
Rabeprazole label
Version not recorded · Effective date not recorded
12.3 Pharmacokinetics After oral administration of 20 mg Rabeprazole Sodium Delayed-Release Tablets, peak plasma concentrations (C max ) of rabeprazole occur over a range of 2 to 5 hours (T max ).
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:c5c43222-d167-4152-b5c7-84b55920a7ce (opens source in a new tab)
Rabeprazole label
Version not recorded · Effective date not recorded
No data are available on long-term treatment with Rabeprazole Sodium Delayed-Release Tablets and ocular effects. 12.3 Pharmacokinetics After oral administration of 20 mg Rabeprazole Sodium Delayed-Release Tablets, peak plasma concentrations (C max ) of rabeprazole occur over a range of 2 to 5 hours (T max ).
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:3b6a25c2-fb61-4c86-9988-c6ffac7939c4 (opens source in a new tab)
Rabeprazole label
Version not recorded · Effective date not recorded
12.3 Pharmacokinetics After oral administration of 20 mg rabeprazole sodium delayed-release tablets, peak plasma concentrations (C max ) of rabeprazole occur over a range of 2 to 5 hours (T max ).
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:9237eaa4-8eec-fb2a-e053-2995a90ab6c0 (opens source in a new tab)
Rabeprazole label
Version not recorded · Effective date not recorded
12.3 Pharmacokinetics After oral administration of 20 mg rabeprazole sodium delayed-release tablets, peak plasma concentrations (C max ) of rabeprazole occur over a range of 2 to 5 hours (T max ).
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:63e0b7ca-6b2d-42a9-b9d4-4523b8a20425 (opens source in a new tab)
Rabeprazole label
Version not recorded · Effective date not recorded
12.3 Pharmacokinetics After oral administration of 20 mg rabeprazole sodium delayed-release tablets, peak plasma concentrations (C max ) of rabeprazole occur over a range of 2 to 5 hours (T max ).
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:d11c3211-b4d4-4893-8c1c-b8fb6d0a0b89 (opens source in a new tab)
Rabeprazole label
Version not recorded · Effective date not recorded
12.3 Pharmacokinetics After oral administration of 20 mg rabeprazole sodium delayed-release tablets, peak plasma concentrations (C max ) of rabeprazole occur over a range of 2 to 5 hours (T max ).
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:12eaf996-db61-41d6-82e1-fa6196435603 (opens source in a new tab)
Rabeprazole label
Version not recorded · Effective date not recorded
12.3 Pharmacokinetics After oral administration of 20 mg rabeprazole sodium delayed-release tablets, peak plasma concentrations (C max ) of rabeprazole occur over a range of 2 to 5 hours (T max ).
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:b1b7def0-834f-37f5-e053-2a95a90ade1f (opens source in a new tab)
Rabeprazole label
Version not recorded · Effective date not recorded
No data are available on long-term treatment with rabeprazole sodium delayed-release tablets and ocular effects. 12.3 Pharmacokinetics After oral administration of 20 mg rabeprazole sodium delayed-release tablets, peak plasma concentrations (Cmax) of rabeprazole occur over a range of 2 to 5 hours (Tmax).
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:350c20b0-1879-d4cb-e063-6294a90a37f2 (opens source in a new tab)
Rabeprazole label
Version not recorded · Effective date not recorded
12.3 Pharmacokinetics After oral administration of 20 mg Rabeprazole Sodium delayed-release tablets, peak plasma concentrations (C max ) of rabeprazole occur over a range of 2 to 5 hours (T max ).
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:b354053c-cb83-79c6-e053-2a95a90afdbe (opens source in a new tab)
Rabeprazole label
Version not recorded · Effective date not recorded
No data are available on long-term treatment with rabeprazole sodium delayed-release tablets and ocular effects. 12.3 Pharmacokinetics After oral administration of 20 mg rabeprazole sodium delayed-release tablets, peak plasma concentrations (Cmax) of rabeprazole occur over a range of 2 to 5 hours (Tmax).
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:14412af6-e99c-4264-bc34-28a6f139f252 (opens source in a new tab)
Rabeprazole label
Version not recorded · Effective date not recorded
After oral administration of 20 mg Rabeprazole Sodium Delayed-Release Tablets, peak plasma concentrations (C max ) of rabeprazole occur over a range of 2 to 5 hours (T max ).
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:1855ccab-c377-4962-9225-3c5adc62e2bd (opens source in a new tab)
Rabeprazole label
Version not recorded · Effective date not recorded
12.3 Pharmacokinetics After oral administration of 20 mg rabeprazole sodium delayed-release tablets, peak plasma concentrations (C max ) of rabeprazole occur over a range of 2 to 5 hours (T max ).
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:04e88b86-e1dd-4c56-8359-45fbcc161f7d (opens source in a new tab)
Rabeprazole label
Version not recorded · Effective date not recorded
12.3 Pharmacokinetics After oral administration of 20 mg rabeprazole sodium delayed-release tablets, peak plasma concentrations (C max ) of rabeprazole occur over a range of 2 to 5 hours (T max ).
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:68b7a793-f22b-4609-a640-94fdec703d93 (opens source in a new tab)
Rabeprazole label
Version not recorded · Effective date not recorded
12.3 Pharmacokinetics After oral administration of 20 mg rabeprazole sodium delayed-release tablets, peak plasma concentrations (C max ) of rabeprazole occur over a range of 2 to 5 hours (T max ).
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:9881dbb2-1ce2-4737-989f-b26720791ca5 (opens source in a new tab)
Rabeprazole label
Version not recorded · Effective date not recorded
12.3 Pharmacokinetics After oral administration of 20 mg Rabeprazole Sodium delayed-release tablets, peak plasma concentrations (C max ) of rabeprazole occur over a range of 2 to 5 hours (T max ).
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:3a674849-b2f6-5f43-e063-6294a90a9e20 (opens source in a new tab)
Rabeprazole label
Version not recorded · Effective date not recorded
12.3 Pharmacokinetics After oral administration of 20 mg rabeprazole sodium delayed-release tablets, peak plasma concentrations (C max ) of rabeprazole occur over a range of 2 to 5 hours (T max ).
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:4e8b9858-23a1-4363-b26f-ee6b9ff7ebf9 (opens source in a new tab)
Rabeprazole label
Version not recorded · Effective date not recorded
12.3 Pharmacokinetics After oral administration of 20 mg Rabeprazole Sodium delayed-release tablets, peak plasma concentrations (C max ) of rabeprazole occur over a range of 2 to 5 hours (T max ).
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:0863f340-4c7e-379a-e063-6394a90a758d (opens source in a new tab)
Rabeprazole label
Version not recorded · Effective date not recorded
12.3 Pharmacokinetics After oral administration of 20 mg Rabeprazole Sodium delayed-release tablets, peak plasma concentrations (C max ) of rabeprazole occur over a range of 2 to 5 hours (T max ).
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:8d8c1a72-b4c4-4699-b9c3-3a39a9df44f2 (opens source in a new tab)
Rabeprazole label
Version not recorded · Effective date not recorded
12.3 Pharmacokinetics After oral administration of 20 mg rabeprazole sodium delayed-release tablets, peak plasma concentrations (C max ) of rabeprazole occur over a range of 2 to 5 hours (T max ).
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:b1a12c83-74ab-febc-e053-2a95a90a1441 (opens source in a new tab)
Rabeprazole label
Version not recorded · Effective date not recorded
12.3 Pharmacokinetics After oral administration of 20 mg Rabeprazole Sodium delayed-release tablets, peak plasma concentrations (C max ) of rabeprazole occur over a range of 2 to 5 hours (T max ).
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:7f7d68f0-972b-4315-b712-0bb8a84c85cc (opens source in a new tab)
Rabeprazole label
Version not recorded · Effective date not recorded
12.3 Pharmacokinetics After oral administration of 20 mg Rabeprazole Sodium Delayed-Release Tablets, peak plasma concentrations (C max ) of rabeprazole occur over a range of 2 to 5 hours (T max ).
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:26f8c3bc-4402-e92c-e063-6294a90a9ad7 (opens source in a new tab)
Rabeprazole label
Version not recorded · Effective date not recorded
12.3 Pharmacokinetics After oral administration of 20 mg Rabeprazole Sodium delayed-release tablets, peak plasma concentrations (C max ) of rabeprazole occur over a range of 2 to 5 hours (T max ).
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:1eb38279-0237-4967-be7a-c53a826c1138 (opens source in a new tab)
Rabeprazole label
Version not recorded · Effective date not recorded
12.3 Pharmacokinetics After oral administration of 20 mg ACIPHEX delayed-release tablets, peak plasma concentrations (C max ) of rabeprazole occur over a range of 2 to 5 hours (T max ).
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:bdad0b58-495e-2352-e053-2a95a90a3198 (opens source in a new tab)
Rabeprazole label
Version not recorded · Effective date not recorded
No data are available on long-term treatment with rabeprazole sodium delayed-release tablets and ocular effects. 12.3 Pharmacokinetics After oral administration of 20 mg rabeprazole sodium delayed-release tablets, peak plasma concentrations (Cmax) of rabeprazole occur over a range of 2 to 5 hours (Tmax).
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:4582d443-f1be-4f94-85da-49aa603f54e4 (opens source in a new tab)
Rabeprazole label
Version not recorded · Effective date not recorded
12.3 Pharmacokinetics After oral administration of 20 mg Rabeprazole Sodium delayed-release tablets, peak plasma concentrations (C max ) of rabeprazole occur over a range of 2 to 5 hours (T max ).
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:ac9266ed-a9b2-4e77-8607-393b5dcdd2b6 (opens source in a new tab)
Rabeprazole label
Version not recorded · Effective date not recorded
12.3 Pharmacokinetics After oral administration of 20 mg rabeprazole sodium delayed-release tablets, peak plasma concentrations (C max ) of rabeprazole occur over a range of 2 to 5 hours (T max ).
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:bafff1ac-02fb-4726-b2d7-6e099ae981cb (opens source in a new tab)
Rabeprazole label
Version not recorded · Effective date not recorded
12.3 Pharmacokinetics After oral administration of 20 mg Rabeprazole Sodium delayed-release tablets, peak plasma concentrations (C max ) of rabeprazole occur over a range of 2 to 5 hours (T max ).
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:e6350638-99b0-474d-be75-ae2a3e1af2cf (opens source in a new tab)
Rabeprazole label
Version not recorded · Effective date not recorded
12.3 Pharmacokinetics After oral administration of 20 mg Rabeprazole Sodium Delayed-Release Tablets, peak plasma concentrations (C max ) of rabeprazole occur over a range of 2 to 5 hours (T max ).
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:0f5eb1b4-ad4b-4782-8d3d-cd33f9c5be7d (opens source in a new tab)
Rabeprazole label
Version not recorded · Effective date not recorded
12.3 Pharmacokinetics After oral administration of 20 mg Rabeprazole Sodium delayed-release tablets, peak plasma concentrations (C max ) of rabeprazole occur over a range of 2 to 5 hours (T max ).
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:45092108-7c4a-48f9-8222-ca8612e82189 (opens source in a new tab)
Rabeprazole label
Version not recorded · Effective date not recorded
12.3 Pharmacokinetics After oral administration of 20 mg rabeprazole sodium delayed-release tablets, peak plasma concentrations (C max ) of rabeprazole occur over a range of 2 to 5 hours (T max ).
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:c212c9d5-32d3-3c5f-e053-2a95a90af88b (opens source in a new tab)
Rabeprazole label
Version not recorded · Effective date not recorded
12.3 Pharmacokinetics After oral administration of 20 mg Rabeprazole Sodium delayed-release tablets, peak plasma concentrations (C max ) of rabeprazole occur over a range of 2 to 5 hours (T max ).
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:b35f376a-f2a4-4eb9-80ac-9c20ceb2f0bf (opens source in a new tab)
Rabeprazole label
Version not recorded · Effective date not recorded
12.3 Pharmacokinetics After oral administration of 20 mg rabeprazole sodium delayed-release tablets, peak plasma concentrations (C max ) of rabeprazole occur over a range of 2 to 5 hours (T max ).
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:9ea2552c-873c-4ab2-84b0-dd54e84e4eee (opens source in a new tab)
Rabeprazole label
Version not recorded · Effective date not recorded
12.3 Pharmacokinetics After oral administration of 20 mg rabeprazole sodium delayed-release tablets, peak plasma concentrations (C max ) of rabeprazole occur over a range of 2 to 5 hours (T max ).
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:951caefe-6e18-48ff-9567-beb545b09c25 (opens source in a new tab)
Rabeprazole label
Version not recorded · Effective date not recorded
No data are available on long-term treatment with rabeprazole sodium delayed-release tablets and ocular effects. 12.3 Pharmacokinetics After oral administration of 20 mg rabeprazole sodium delayed-release tablets, peak plasma concentrations (C max ) of rabeprazole occur over a range of 2 to 5 hours (T max ).
2.0 to 5.0 hours
- Numeric value
- 2
- Unit
- hours
- Source records
- 1
Population and context: Unknown: population and formulation context were not structurally extracted from this source sentence.
Show all 1 source records
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:d1444508-fe40-4f68-8350-52f13399e38a (opens source in a new tab)
Rabeprazole label
Version not recorded · Effective date not recorded
After oral administration of 20 mg rabeprazole sodium tablet, peak plasma concentrations (C max ) of rabeprazole occur over a range of 2.0 to 5.0 hours (T max ).
Projected row 1290
- Medicine slug
- raloxifene
- Compared field
- bioavailability
- Comparison state
- agree
- Reason codes
- COMPATIBLE_VALUES_OVERLAP
- Documents examined
- 23
- Source count
- 23
- Agreement rate
- 1
- Recorded readings
2%
- Numeric value
- 2
- Unit
- %
- Source records
- 23
Population and context: Unknown: population and formulation context were not structurally extracted from this source sentence.
Show all 23 source records
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:f5c25553-1546-451d-8069-c0f484c47741 (opens source in a new tab)
Raloxifene label
Version not recorded · Effective date not recorded
Absolute bioavailability of raloxifene is 2%.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:8fef5bfd-a786-4442-b09b-f3b81812cdac (opens source in a new tab)
Raloxifene label
Version not recorded · Effective date not recorded
Absolute bioavailability of raloxifene is 2%.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:804e873e-f48b-4c25-ad7b-41d44f61bdde (opens source in a new tab)
Raloxifene label
Version not recorded · Effective date not recorded
Absolute bioavailability of raloxifene is 2%.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:e8b6cbe0-c1f4-4678-b852-f629a7f6a1b5 (opens source in a new tab)
Raloxifene label
Version not recorded · Effective date not recorded
Absolute bioavailability of raloxifene is 2%.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:3568ed3c-6afd-4872-a861-93a7873bec9c (opens source in a new tab)
Raloxifene label
Version not recorded · Effective date not recorded
Absolute bioavailability of raloxifene is 2%.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:a46bcc4f-f63d-4200-836d-a653a3c616db (opens source in a new tab)
Raloxifene label
Version not recorded · Effective date not recorded
Absolute bioavailability of raloxifene is 2%.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:6fd63a06-5bc5-4c50-9b85-b09c89100b80 (opens source in a new tab)
Raloxifene label
Version not recorded · Effective date not recorded
Absolute bioavailability of raloxifene is 2%.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:53a2db10-4af8-4032-b598-b7c7a0969801 (opens source in a new tab)
Raloxifene label
Version not recorded · Effective date not recorded
Absolute bioavailability of raloxifene is 2%.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:2b94ecf5-d870-4132-b455-d5ee5c9dce56 (opens source in a new tab)
Raloxifene label
Version not recorded · Effective date not recorded
Absolute bioavailability of raloxifene is 2%.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:c05521f8-95d2-44b8-8433-eba539c0f84c (opens source in a new tab)
Raloxifene label
Version not recorded · Effective date not recorded
Absolute bioavailability of raloxifene is 2%.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:8152e68b-61a8-4897-8e03-900135b1dbd5 (opens source in a new tab)
Raloxifene label
Version not recorded · Effective date not recorded
Absolute bioavailability of raloxifene is 2%.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:6f7eb934-aa60-51e1-e053-2a91aa0a3914 (opens source in a new tab)
Raloxifene label
Version not recorded · Effective date not recorded
Absolute bioavailability of raloxifene is 2%.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:22a951ee-2ffc-4c60-b681-0f80285153e1 (opens source in a new tab)
Raloxifene label
Version not recorded · Effective date not recorded
Absolute bioavailability of raloxifene is 2%.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:fcaaa6dc-74e8-4fb8-800c-5574bf0f8de9 (opens source in a new tab)
Raloxifene label
Version not recorded · Effective date not recorded
Absolute bioavailability of raloxifene is 2%.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:ad3ef791-ac90-4f66-8da6-95b31e4c3eb6 (opens source in a new tab)
Raloxifene label
Version not recorded · Effective date not recorded
Absolute bioavailability of raloxifene is 2%.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:8f24455c-34dc-4e07-bcd3-24326b9cc377 (opens source in a new tab)
Raloxifene label
Version not recorded · Effective date not recorded
Absolute bioavailability of raloxifene is 2%.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:5a22ae27-1c55-487b-8e93-8ef1cec87065 (opens source in a new tab)
Raloxifene label
Version not recorded · Effective date not recorded
Absolute bioavailability of raloxifene is 2%.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:e2967d3c-238c-40cf-b3d8-89482a502928 (opens source in a new tab)
Raloxifene label
Version not recorded · Effective date not recorded
Absolute bioavailability of raloxifene is 2%.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:e6be5b1d-757d-4bab-ad6a-c421960a104d (opens source in a new tab)
Raloxifene label
Version not recorded · Effective date not recorded
Absolute bioavailability of raloxifene is 2%.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:7e4bfee5-fefc-4115-9bdb-222eccefca83 (opens source in a new tab)
Raloxifene label
Version not recorded · Effective date not recorded
Absolute bioavailability of raloxifene is 2%.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:0f7d1f81-374f-4ad5-aea0-2f97abbe1dbf (opens source in a new tab)
Raloxifene label
Version not recorded · Effective date not recorded
Absolute bioavailability of raloxifene is 2%.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:f0db29f5-28da-4165-94f8-24727b6b71e5 (opens source in a new tab)
Raloxifene label
Version not recorded · Effective date not recorded
Absolute bioavailability of raloxifene is 2%.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:3798c70b-a4b0-4811-9788-e4c9cff47ebe (opens source in a new tab)
Raloxifene label
Version not recorded · Effective date not recorded
Absolute bioavailability of raloxifene is 2%.
Access
Query or download the projection
GET /api/datasets/source-consensus?limit=10&offset=1280Allowed query parameters
- q
- Case-insensitive text search over the public fields named for this dataset.
- state
- Exact comparability state.Values: agree, differ, not_comparable, insufficient_context
- field
- Exact recorded field key.Values: bioavailability, halfLife, proteinBinding, tMax, volumeOfDistribution
- limit / offset
- Pagination is required. limit is at most 200; offset is bounded. Set format=csv for the same projected page as a download.
Reuse and corrections
Keep the boundary attached
CC BY 4.0 applies to RNAWiki licenses its selection, schema, structure, and derived projection. Quoted source passages and third-party records retain their original rights.
Cite RNAWiki, this dataset identifier, and the generated date. Keep the “does not mean” statement with any downstream display so a corpus measurement is not mistaken for medical advice.